Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for craving in hospitalized patients with cocaine addiction
2018-000420-34Phase 2Completed
- Sponsor
- CHU Brugmann
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetylcysteine in cocaine use disorder (CUD), sponsored by CHU Brugmann. Primary endpoint: Craving intensity (Likert scale). Started Mar 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on 2018-000420-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000420-34.